You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

What Have We Learned About Managing Patients With Inflammatory Diseases During the COVID-19 Pandemic?

  • Authors: Tim Raine, MD; Christopher Griffiths, OBE, MD, FMedSci; Georg Schett, MD
  • CPD Released: 7/30/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 7/30/2021
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US gastroenterologists, dermatologists, and rheumatologists.

The goal of this activity is to increase clinicians' knowledge and competence regarding the management of patients with chronic immune-mediated inflammatory diseases (IMIDs) during the coronavirus disease 2019 (COVID-19) pandemic.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest information on COVID-19 and its impact on patients with inflammatory diseases
    • Latest information on safety of continuation of biologic therapies in virus-naive or infected patients
  • Have greater competence related to
    • Managing patients with inflammatory disease who are infected with COVID-19


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Faculty

  • Timothy Raine, MD

    Gastroenterologist
    Addenbrooke's Hospital
    Cambridge University Hospitals
    Cambridge, UK

    Disclosures

    Disclosure: Timothy Raine, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Bristol Myers Squibb Company; Celgene; Ferring; Gilead; GlaxoSmithKline; LabGenius; Janssen Pharmaceutical Companies; Mylan; Merck Sharp & Dohme; Novartis; Pfizer; Sandoz; Takeda; UCB
    Received grants for clinical research from: AbbVie

  • Christopher Griffiths, OBE, MD, FMedSci

    Foundation Professor of Dermatology
    Consultant Dermatologist Director
    University of Manchester
    Manchester, UK

    Disclosures

    Disclosure: Christopher Griffiths, OBE, MD, FMedSci, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Almirall; Celgene; Eli Lilly; Janssen Pharmaceutical Companies; Novartis; Sandoz
    Served as a speaker or a member of a speakers bureau for: AbbVie; Almirall; Celgene; Eli Lilly; Janssen Pharmaceutical Companies; Novartis; UCB
    Received grants for clinical research from: AbbVie; Celgene; Eli Lilly; Janssen Pharmaceutical Companies; Novartis; UCB

  • Georg Schett, MD

    Chief
    Internal Medicine 3
    Universitätsklinikum Erlangen
    Friedrich-Alexander Universität
    Erlangen-Nürnberg, Germany

    Disclosures

    Disclosure: Prof Georg Schett, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie; Bristol Myers Squibb Company; Celgene; Chugai; Eli Lilly; Gilead; Janssen Pharmaceutical Companies; Novartis; Roche; UCB
    Served as a speaker or a member of a speakers bureau for: AbbVie; Brisotl Myers Squibb; Celgene; Chugai; Eli Lilly; Gilead; Janssen Pharmaceutical Companies; Novartis; Roche; UCB
    Received grants for clinical research from: Bristol Myers Squibb; Celgene; Chugai; Eli Lilly; Novartis; Roche

Editors

  • Roderick Smith, MS

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Roderick Smith, MS, has disclosed no relevant financial relationships.

  • Rosalyn Blumenthal, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Roz Blumenthal, PhD, has disclosed no relevant financial relationships.

Content Reviewer

  • Anjali Mehra, MD

    Lead Medical Education Director

    Disclosures

    Disclosure: Anjali Mehra, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

What Have We Learned About Managing Patients With Inflammatory Diseases During the COVID-19 Pandemic?

Authors: Tim Raine, MD; Christopher Griffiths, OBE, MD, FMedSci; Georg Schett, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CPD Released: 7/30/2020

Valid for credit through: 7/30/2021

processing....

Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available.

Contents of This CPD Activity

All sections of this activity are required for credit.

COVID-19 and Inflammatory Bowel Disease
Dr Raine discusses the impact of COVID-19 on patients with IBD.
Timothy Raine, MD
COVID-19 and Psoriasis
Dr Griffiths discusses the impact of COVID-19 on patients with psoriasis.
Christopher Griffiths, OBE, MD, FMedSci
COVID-19 and Rheumatologic Diseases
Dr Schett concludes with a discussion about the impact of COVID-19 on patients with rheumatic diseases.
Prof Georg Schett, MD